These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 25496519)

  • 1. Tumour necrosis factor-α/interleukin-10 ratio in patients with obstructive sleep apnoea hypopnoea syndrome.
    Jiang H; Cao H; Wang P; Liu W; Cao F; Chen J
    J Laryngol Otol; 2015 Jan; 129(1):73-8. PubMed ID: 25496519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea.
    Arias MA; García-Río F; Alonso-Fernández A; Hernanz A; Hidalgo R; Martínez-Mateo V; Bartolomé S; Rodríguez-Padial L
    Eur Respir J; 2008 Oct; 32(4):1009-15. PubMed ID: 18508832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.
    Marin JM; Carrizo SJ; Vicente E; Agusti AG
    Lancet; 2005 Mar 19-25; 365(9464):1046-53. PubMed ID: 15781100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of modern surgical treatment on the inflammatory/anti-inflammatory balance in patients with obstructive sleep apnoea.
    Binar M; Akcam TM; Karakoc O; Sagkan RI; Musabak U; Gerek M
    J Laryngol Otol; 2017 Aug; 131(8):719-727. PubMed ID: 28534455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long term effect of autoadjusting positive airway pressure on C-reactive protein and interleukin-6 in men with obstructive sleep apnoea syndrome].
    Drummond M; Winck J; Guimarães J; Santos AC; Almeida J; Marques J
    Arch Bronconeumol; 2009 Dec; 45(12):577-84. PubMed ID: 19552994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nCPAP therapy on heart rate in patients with obstructive sleep apnoea-hypopnoea.
    Sumi K; Chin K; Takahashi K; Nakamura T; Matsumoto H; Niimi A; Mishima M
    QJM; 2006 Aug; 99(8):545-53. PubMed ID: 16861714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous positive airway pressure in clinically stable patients with mild-to-moderate obesity hypoventilation syndrome and obstructive sleep apnoea.
    Salord N; Mayos M; Miralda RM; Farré A; Carreras M; Sust R; Masuet-Aumatell C; Rodríguez J; Pérez A
    Respirology; 2013 Oct; 18(7):1135-42. PubMed ID: 23714281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term persistence of obstructive sleep apnoea-hypopnoea syndrome in children treated with adenotonsillectomy. Analysis of prognostic factors].
    Esteller Moré E; Santos Acosta P; Segarra Isern F; Lopez Diu R; Matiño Soler E; Ademà Alcover JM; Estivill Sancho E
    Acta Otorrinolaringol Esp; 2012; 63(2):85-92. PubMed ID: 22342641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tonsil size and body mass index are important factors for efficacy of simple tonsillectomy in obstructive sleep apnoea syndrome.
    Nakata S; Noda A; Yanagi E; Suzuki K; Yamamoto H; Nakashima T
    Clin Otolaryngol; 2006 Feb; 31(1):41-5. PubMed ID: 16441801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea.
    Sahlman J; Miettinen K; Peuhkurinen K; Seppä J; Peltonen M; Herder C; Punnonen K; Vanninen E; Gylling H; Partinen M; Uusitupa M; Tuomilehto H;
    J Sleep Res; 2010 Jun; 19(2):341-8. PubMed ID: 20040038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of topical corticosteroids on allergic airway inflammation and disease severity in obstructive sleep apnoea.
    Lavigne F; Petrof BJ; Johnson JR; Lavigne P; Binothman N; Kassissia GO; Al Samri M; Giordano C; Dubé N; Hercz D; Benedetti A; Hamid Q
    Clin Exp Allergy; 2013 Oct; 43(10):1124-33. PubMed ID: 24074330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a new simple treatment for positional sleep apnoea patients.
    van Maanen JP; Richard W; Van Kesteren ER; Ravesloot MJ; Laman DM; Hilgevoord AA; de Vries N
    J Sleep Res; 2012 Jun; 21(3):322-9. PubMed ID: 22017727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome.
    Riha RL; Brander P; Vennelle M; McArdle N; Kerr SM; Anderson NH; Douglas NJ
    Eur Respir J; 2005 Oct; 26(4):673-8. PubMed ID: 16204600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intensified diuretic therapy on overnight rostral fluid shift and obstructive sleep apnoea in patients with uncontrolled hypertension.
    Kasai T; Bradley TD; Friedman O; Logan AG
    J Hypertens; 2014 Mar; 32(3):673-80. PubMed ID: 24284499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory measures in children with obstructive sleep apnoea.
    Tam CS; Wong M; McBain R; Bailey S; Waters KA
    J Paediatr Child Health; 2006 May; 42(5):277-82. PubMed ID: 16712558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstructive sleep apnea in normal weight patients: characteristics and comparison with overweight and obese patients.
    Dacal Quintas R; Tumbeiro Novoa M; Alves Pérez MT; Santalla Martínez ML; Acuña Fernández A; Marcos Velázquez P
    Arch Bronconeumol; 2013 Dec; 49(12):513-7. PubMed ID: 23871526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous positive airway pressure therapy lowers vagal tone in patients with obstructive sleep apnoea-hypopnoea syndrome.
    Chrysostomakis SI; Simantirakis EN; Schiza SE; Karalis IK; Klapsinos NC; Siafakas NM; Vardas PE
    Hellenic J Cardiol; 2006; 47(1):13-20. PubMed ID: 16532711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mandibular advancement therapy on inflammatory and metabolic biomarkers in patients with severe obstructive sleep apnoea: a randomised controlled trial.
    Recoquillon S; Pépin JL; Vielle B; Andriantsitohaina R; Bironneau V; Chouet-Girard F; Fleury B; Goupil F; Launois S; Martinez MC; Meslier N; Nguyen XL; Paris A; Priou P; Tamisier R; Trzepizur W; Gagnadoux F
    Thorax; 2019 May; 74(5):496-499. PubMed ID: 30366971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum levels of advanced glycation end-products is associated with severity of sleep disordered breathing but not insulin sensitivity in non-diabetic men with obstructive sleep apnoea.
    Lam JC; Tan KC; Lai AY; Lam DC; Ip MS
    Sleep Med; 2012 Jan; 13(1):15-20. PubMed ID: 22137116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A urine biomarker for severe obstructive sleep apnoea patients: lipocalin-type prostaglandin D synthase.
    Chihara Y; Chin K; Aritake K; Harada Y; Toyama Y; Murase K; Yoshimura C; Hitomi T; Oga T; Mishima M; Urade Y
    Eur Respir J; 2013 Dec; 42(6):1563-74. PubMed ID: 23222881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.